BIRMINGHAM, Ala., Oct. 24 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals (Nasdaq: BCRX) today announced that its third quarter 2008 financial results will be released on Friday, October 31, 2008. Following the release, BioCryst will host a conference call and Web cast at 8:30 a.m. Eastern Time to discuss the financial results and provide an update on the Company's programs. The call will be led by Jon P. Stonehouse, President and Chief Executive Officer, Stuart Grant, Chief Financial Officer and Dr. William P. Sheridan, Chief Medical Officer.
The Web cast can be accessed by logging onto http://www.biocryst.com. Please connect to the Web site at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed. To participate in the conference call, please dial 1-800-860-2442 (United States) or 1-412-858-4600 (International). No passcode is needed for the call. The audio portion of the Web cast will be archived and available for replay for 14 days.
BioCryst is an integrated biopharmaceutical company utilizing
crystallography and structure-based drug design to develop a deep pipeline
of novel therapeutics targeting major illnesses. BioCryst is currently
advancing investigational new drugs discovered in-house in late-stage
clinical trials for influenza and lymphoma. In addition, the Company has a
pre-clinical portfolio of novel compounds, directed against infectious,
cardiovascular, and autoimmune disease targets, to create long-term
sustainable value. The Company's strategic alliances with the U.S.
Department of Health and Human Services, Shionogi & Co., Ltd., Green Cross
Corporation and Mundipharma In
|SOURCE BioCryst Pharmaceuticals|
Copyright©2008 PR Newswire.
All rights reserved